HomeNDC LookupIngredientsMinoxidil › 69968-0090-03
🧴image loading
(from DailyMed)

Womens Rogaine Unscented Minoxidil 20 mg/mL Solution

by Kenvue Brands LLC · 3 BOTTLE, PLASTIC in 1 CARTON (69968-0090-3) / 60 mL in 1 BOTTLE, PLASTIC
NDC 69968-0090-03
🏷️ FDA NDC (as labeled) 69968-0090-3 billing pads the package segment with a zero
This package
Contains60 mL in 1 bottle, plastic Pack sizes2 compare ↓
Also comes in: 60 mL 69968-0090-01
OTC Brand On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 69968-0090-3
Product NDC 69968-0090
11-digit billing NDC 69968009003
NCPDP billing unit ML — per mL (volume)
RxCUI 207371, 311723
UNII 5965120SH1
UPC 0312547780209
Application # NDA019501
SPL Set ID 8bf0000c-95f3-4a4d-830b-f5ac1539823d
Established class (EPC) Arteriolar Vasodilator
Physiologic effect Arteriolar Vasodilation
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-08-01
Route TOPICAL
Dosage form SOLUTION
Substance MINOXIDIL
Why two NDCs? The FDA registers this code as 69968-0090-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 69968-0090-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Arteriolar Vasodilator class.

Pharmacologic class Arteriolar Vasodilator
Drug family (ATC) Pyrimidine derivatives, Other dermatologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerKenvue Brands LLC
Application holderKENVUE BRANDS LLC
FDA applicationNDA019501 (NDA)
Labeler code69968
First marketedAug 2010
Product typeHuman Otc Drug
Portfolio564 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • That's a really common question. Minoxidil tablets are very effective at lowering blood pressure, but they cause two side effects that need to be managed: your heart speeds up, and...
  • I've been prescribed minoxidil tablets for blood pressure — why do I need to take other pills with it?
  • It takes patience — most people need at least 2 to 4 months of twice-daily use before they notice any regrowth. Some products note that results can start appearing around the 2-mon...
  • I'm using a topical minoxidil solution for hair loss. How long before I see results?
📖 Read our full Minoxidil guide →
1
Nutrient depletion considerations

Minoxidil may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 mL
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Hair Regrowth Treatment 2 g/100mL 00113-6500-00 L. 3 bottles FDA listed
hair regrowth treatment 2 g/100mL 00363-0703-16 Walgreen 1 bottle FDA listed
Minoxidil 2 g/100mL 00363-9970-02 Walgreens 1 bottle FDA listed
up and up hair regrowth treatment for women 2 g/100mL 11673-0919-30 Target 3 bottles FDA listed
carols daughter hair regrowth treatment 2 g/100mL 49967-0988-01 L'Oreal 1 bottle FDA listed
Womens Minoxidil Hair Growth System 20 mg/mL 51326-0161-01 Topiderm, 60 ml FDA listed
Minoxidil Topical Solution 2% 20 mg/mL 51672-2152-04 SUN 1 bottle FDA listed
minoxidil 2 g/100mL 56062-0070-16 Publix 1 bottle FDA listed
minoxidil topical 2 g/100mL 59640-0000-16 H 1 bottle FDA listed
BOSLEY Woman 2 Minoxidil Topical Solution 20 mg/mL 69113-0432-00 Scientific 1 bottle FDA listed
BOSLEY Minoxidil Topical Solution 2 for Women 20 mg/mL 69113-0462-00 Scientific 1 bottle FDA listed
Foligain Professional Series Extra Strength for Women Minoxidil Topical Hair Regrowth Treatment 20 mg/mL 69607-9530-00 WR 3 bottles FDA listed
hair regrowth treatment 2 g/100mL 69842-0797-16 CVS 1 bottle FDA listed
Womens Rogaine Unscented 20 mg/mLthis 69968-0090-03 Kenvue 3 bottles FDA listed
Leader minoxidil 2 g/100mL 70000-0728-01 Cardinal 3 bottles FDA listed
Keranique 2% Hair Regrowth Treatment for Women 20 mg/mL 70550-0576-01 PROFECTUS 1 bottle FDA listed
hers hair regrowth treatment 2 g/100mL 71730-0023-16 Hims 1 bottle FDA listed
MDhair hair regrowth treatment for women 2 g/100mL 71804-0711-02 MDalgorithms, 1 bottle FDA listed
basic care hair regrowth treatment 2 g/100mL 72288-0202-30 Amazon.com 3 bottles FDA listed
basic care hair regrowth treatment 2 g/100mL 72288-0701-16 Amazon.com 1 bottle FDA listed
Gemachlich ZuHause Hair Growth Serum (Women) 2 g/100mL 76986-0012-01 Guangdong 8 bottles FDA listed
hair regrowth treatment 2 g/100mL 79481-0070-01 Meijer, 3 bottles FDA listed
equate hair regrowth treatment 2 g/100mL 79903-0072-30 WALMART 3 bottles FDA listed
Santo Remedio Womens Hair Regrowth Treatment Minoxidil Unscented 20 mg/mL 81352-0561-00 SANTO 1 bottle FDA listed
Remixdil Hair Regrowth Treatment For Women 2 g/100mL 83004-0009-01 Rida 4 bottles FDA listed
Hair Regen Hair Regrowth Treatment 2 g/100mL 84232-0004-01 YIWUYIZHOUTRADINGCO.,LTD 60 ml FDA listed
GROWELL Womens Hair Regrowth Treatment 2 Minoxidil 20 mg/mL 84329-0466-00 APIRA 1 bottle FDA listed
The Root Of Goodness Healthy Growth Hair Regrowth System For Women 3 Step System 84828-0569-00 Invest 1 kit FDA listed
eSalon Hair Regrowth Treatment Womens Minoxidil 20 mg/mL 84856-0604-00 ESALON.COM, 1 bottle FDA listed
Happy Head Womens Hair Regrowth Treatment 20 mg/mL 87117-0880-00 Happy 3 bottles FDA listed
Womens MinoGrow Hair Regrowth Treatment Minoxidil 20 mg/mL 87387-0980-00 Minogro 1 bottle FDA listed
Fete Health Hair Regrowth Treatment for Women 20 mg/mL 87412-0981-00 Honest 1 bottle FDA listed
Minoxidil Topical Solution USP, 2% .02 g/mL 87532-0001-01 Carol's 1 bottle FDA listed
About this product: this is the brand-name version. Some generic versions are approved by the FDA, but we could not confirm current pharmacy availability from our pricing/market data.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2010
On the market since
Aug 2010
📍
2026
Currently FDA-listed
16 years listed
🔒
·
Generic approved (availability unconfirmed)
see note
🔒Generic approved by FDA, but pharmacy availability is not confirmed

The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Minoxidil (matched by generic name) — the program that covers self-administered drugs. 3 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Minoxidil. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$3.5M
Claims incl. refills
260.9K
Beneficiaries
202.1K
Spend / beneficiary
$17.33
Spend / claim
$13.42
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
69968-0090-01 1 BOTTLE, PLASTIC in 1 CARTON (69968-0090-1) / 60 mL in 1 BOTTLE, PLASTIC 2010-08-01 Active
69968-0090-03 You're viewing this 3 BOTTLE, PLASTIC in 1 CARTON (69968-0090-3) / 60 mL in 1 BOTTLE, PLASTIC 2010-08-01 Active

Pack size FAQ

What quantity is in NDC 69968-0090-03?
NDC 69968-0090-03 is listed by the FDA — 3 bottle, plastic in 1 carton / 60 ml in 1 bottle, plastic.
What NDC number is used to bill for this package of Womens Rogaine Unscented Minoxidil 20 mg/mL Solution?
Bill NDC 69968-0090-03 — the 11-digit billing format is 69968009003. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 69968-0090-3, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 69968-0090-03, written without dashes as 69968009003. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 69968-0090-03, the first segment (69968) is the labeler code FDA assigned to Kenvue Brands LLC; the middle segment (0090) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (03) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Kenvue Brands LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 bottle (69968-0090-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Kenvue Brands LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 7 words

Use to regrow hair on the scalp

⏱️ Dosage and Administration 45 words

Directions apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area using more or more often will not improve results continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again

⚠️ Warnings ~1 min read

Warnings For external use only Flammable: Keep away from fire or flame Do not use if your degree of hair loss is different than that shown on the side of this carton, because this product may not work for you you have no family history of hair loss your hair loss is sudden and/or patchy your hair loss is associated with childbirth you do not know the reason for your hair loss you are under 18 years of age. Do not use on babies and children. your scalp is red, inflamed, infected, irritated, or painful you use other medicines on the scalp Ask a doctor before use if you have heart disease When using this product do not apply on other parts of the body avoid contact with the eyes.

In case of accidental contact, rinse eyes with large amounts of cool tap water. some people have experienced changes in hair color and/or texture it takes time to regrow hair. You may need to use this product 2 times a day for at least 4 months before you see results. the amount of hair regrowth is different for each person. This product will not work for everyone.

Stop use and ask a doctor if chest pain, rapid heartbeat, faintness, or dizziness occurs sudden, unexplained weight gain occurs your hands or feet swell scalp irritation or redness occurs unwanted facial hair growth occurs you do not see hair regrowth in 4 months May be harmful if used when pregnant or breast-feeding. Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 124 words

Other information see hair loss pictures on side of this carton before use, read all information on carton and enclosed booklet keep the carton. It contains important information. In clinical studies of mostly white women aged 18-45 years with mild to moderate degrees of hair loss, the following response to 2% minoxidil topical solution was reported: 19% of women reported moderate hair regrowth after using 2% minoxidil topical solution for 8 months (19% had moderate regrowth; 40% had minimal regrowth).

This compares with 7% of women reporting moderate hair regrowth after using the placebo, the liquid without minoxidil in it, for 8 months (7% had moderate regrowth; 33% had minimal regrowth). store at controlled room temperature 20° to 25° C (68° to 77° F)

🧪 Active Ingredient 5 words

Active ingredient Minoxidil 2% w/v

🧪 Inactive Ingredients 7 words

Inactive ingredients alcohol, propylene glycol, purified water

🎯 Purpose 4 words

Purpose Hair regrowth treatment

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.